AUTOLUS THERAPEUTICS PLC (AUTL) Stock Analyst Earnings Estimates
NASDAQ:AUTL - Nasdaq - US05280R1005 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.36M 172.96% | 1.698M -73.30% | 10.12M 496.00% | 57.915M 472.28% | 124.47M 114.92% | 264.96M 112.87% | 465.65M 75.74% | 672.66M 44.46% | 763.97M 13.57% | 911.65M 19.33% | 1.032B 13.20% | |
| EBITDA YoY % growth | -160.11M -2.73% | -168.963M -5.53% | -233.073M -37.94% | -227.924M 2.21% | -201.196M 11.73% | -152.897M 24.01% | -106.046M 30.64% | 181.12M 270.79% | N/A | N/A | N/A | |
| EBIT YoY % growth | -167.53M -1.95% | -175.528M -4.77% | -240.789M -37.18% | -237.741M 1.27% | -210.575M 11.43% | -109.017M 48.23% | 13.41M 112.30% | 182.1M 1,257.94% | 277.26M 52.26% | 384.27M 38.60% | 467.3M 21.61% | |
| Operating Margin | -2,634.12% | -10,337.34% | -2,379.34% | -410.50% | -169.18% | -41.14% | 2.88% | 27.07% | 36.29% | 42.15% | 45.28% | |
| EPS YoY % growth | -1.57 20.36% | -1.20 23.52% | -0.87 27.50% | -0.93 -6.92% | -0.81 12.72% | -0.57 30.36% | -0.21 62.17% | 0.39 284.31% | 0.72 82.41% | 1.33 85.11% | 1.38 3.45% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.24 -9.28% | -0.24 23.38% | -0.24 -136.06% | -0.24 8.46% | -0.23 2.42% | -0.23 1.23% | -0.22 4.94% |
| Revenue Q2Q % growth | 13.163M | 16.787M | 20.784M 71,568.97% | 19.754M 119.93% | 23.211M 76.34% | 26.174M 55.92% | 29.632M 42.57% |
| EBITDA Q2Q % growth | -75.48M -53.21% | -77.826M -25.50% | -81.804M -20.04% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -63.057M -24.70% | -61.792M 8.66% | -61.531M 18.89% | -52.918M 18.88% | -63.092M -0.06% | -62.408M -1.00% | -60.498M 1.68% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.26 -8.33% | -0.26 | -0.01 | -1.96% |
| Q4 2024 Q2Q % growth | -0.10 77.78% | -0.21 | 0.11 | 52.34% |
| Q3 2024 Q2Q % growth | -0.31 -19.23% | -0.22 | -0.09 | -41.83% |
| Q2 2024 Q2Q % growth | -0.22 15.38% | -0.20 | -0.02 | -11.01% |
| Q1 2024 Q2Q % growth | -0.24 -4.35% | -0.06 | -0.18 | -327.81% |
| Q4 2023 Q2Q % growth | -0.45 -95.65% | -0.26 | -0.19 | -74.72% |
| Q3 2023 Q2Q % growth | -0.26 44.56% | -0.26 | -0.01 | -1.96% |
| Q2 2023 Q2Q % growth | -0.26 43.48% | -0.23 | -0.03 | -13.65% |
| Q1 2023 Q2Q % growth | -0.23 43.90% | -0.27 | 0.04 | 15.31% |
| Q4 2022 Q2Q % growth | -0.23 54.90% | -0.27 | 0.04 | 16.10% |
| Q3 2022 Q2Q % growth | -0.47 0.21% | -0.47 | 0.00 | 1.00% |
| Q2 2022 Q2Q % growth | -0.46 2.13% | -0.43 | -0.03 | -7.38% |
| Q1 2022 Q2Q % growth | -0.41 21.15% | -0.49 | 0.08 | 16.45% |
| Q4 2021 Q2Q % growth | -0.51 38.55% | -0.47 | -0.04 | -8.36% |
| Q3 2021 Q2Q % growth | -0.47 34.72% | -0.52 | 0.05 | 8.86% |
| Q2 2021 Q2Q % growth | -0.47 24.19% | -0.51 | 0.04 | 7.64% |
| Q1 2021 Q2Q % growth | -0.52 13.33% | -0.62 | 0.10 | 15.67% |
| Q4 2020 Q2Q % growth | -0.83 1.19% | -0.78 | -0.05 | -6.29% |
| Q3 2020 Q2Q % growth | -0.72 -18.03% | -0.72 | 0.00 | 0.11% |
| Q2 2020 Q2Q % growth | -0.62 4.62% | -0.72 | 0.10 | 14.25% |
| Q1 2020 Q2Q % growth | -0.60 13.04% | -0.76 | 0.16 | 20.69% |
| Q4 2019 Q2Q % growth | -0.84 | -0.75 | -0.09 | -11.54% |
| Q3 2019 Q2Q % growth | -0.61 | -0.86 | 0.25 | 29.23% |
| Q2 2019 Q2Q % growth | -0.65 | -0.77 | 0.12 | 15.93% |
| Q1 2019 Q2Q % growth | -0.69 | -0.59 | -0.10 | -16.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 8.982M -10.99% | 2.106M | 6.876M | 326.50% |
| Q4 2024 Q2Q % growth | 29K | 3.039M | -3.01M | -99.05% |
| Q3 2024 Q2Q % growth | -100.00% | 131.753K | -131.753K | -100.00% |
| Q2 2024 Q2Q % growth | 63.75K | -63.75K | -100.00% | |
| Q1 2024 Q2Q % growth | 10.091M 681.04% | 25.5M | -15.409M | -60.43% |
| Q4 2023 Q2Q % growth | -100.00% | 365.568K | -365.568K | -100.00% |
| Q3 2023 Q2Q % growth | 406K -82.87% | 455.216K | -49.216K | -10.81% |
| Q2 2023 Q2Q % growth | 139.23K | -139.23K | -100.00% | |
| Q1 2023 Q2Q % growth | 1.292M 660.00% | 360.193K | 931.807K | 258.70% |
| Q4 2022 Q2Q % growth | 3.83M 2,027.78% | 3.262M | 568K | 17.41% |
| Q3 2022 Q2Q % growth | 2.37M 887.50% | 137.7K | 2.232M | 1,621.13% |
| Q2 2022 Q2Q % growth | -100.00% | 245.371K | -245.371K | -100.00% |
| Q1 2022 Q2Q % growth | 170K -37.04% | 288.517K | -118.517K | -41.08% |
| Q4 2021 Q2Q % growth | 180K -55.00% | 200.94K | -20.94K | -10.42% |
| Q3 2021 Q2Q % growth | 240K -64.71% | 253.297K | -13.297K | -5.25% |
| Q2 2021 Q2Q % growth | 1.65M 468.97% | 197.992K | 1.452M | 733.37% |
| Q1 2021 Q2Q % growth | 270K -20.59% | 351.778K | -81.778K | -23.25% |
| Q4 2020 Q2Q % growth | 400K 29.03% | 346.678K | 53.322K | 15.38% |
| Q3 2020 Q2Q % growth | 680K 126.67% | 309.172K | 370.828K | 119.94% |
| Q2 2020 Q2Q % growth | 290K -14.71% | 385.121K | -95.121K | -24.70% |
| Q1 2020 Q2Q % growth | 340K -82.65% | 612K | -272K | -44.44% |
| Q4 2019 Q2Q % growth | 310K | 529.584K | -219.584K | -41.46% |
| Q3 2019 Q2Q % growth | 300K | 591.6K | -291.6K | -49.29% |
| Q2 2019 Q2Q % growth | 340K | 637.5K | -297.5K | -46.67% |
| Q1 2019 Q2Q % growth | 1.96M | 102K | 1.858M | 1,821.57% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.61% | 7.93% | 0% | -0.82% |
| Revenue | 0% | 145.72% | 1.87% | 51.5% |